ORAL PRESENTATIONS
暂无分享,去创建一个
Jane M Blazeby | David Moher | Douglas G Altman | Elizabeth Gargon | Paula R Williamson | Mike Clarke | Declan Devane | Peter Tugwell | Jamie J Kirkham | Sean Tunis | R. Bootzin | J. Dorrian | S. Smith | G. Belenky | H. Hiscock | M. Davey | D. Hillman | D. Dawson | M. Knuiman | S. Lockley | S. Rajaratnam | P. Eastwood | K. Maddison | R. Pierce | G. Roach | S. Jay | N. Lamond | S. Ferguson | S. Baulk | P. Rock | J. Kirkness | C. Dakin | R. Grunstein | T. Sletten | P. Catcheside | R. Reed | T. Oei | F. Bashir | P. Swann | J. Walsh | L. Signal | A. Weissenfeld | N. Antic | C. Parsley | D. McEvoy | D. Stadler | D. Bruck | Jochen Schmitt | P. Gander | A. Segal | M. Harris | K. O'Keeffe | S. Cullen | M. Mcmahon | L. Canterford | J. Harris | K. Wong | C. Heuvel | L. Lack | Sarah Gorst | L. Palmer | J. Trinder | A. Peters | C. Chai | G. Paech | A. Esterman | S. Zhu | D. O'Driscoll | G. Nixon | M. Cooper | J. Lee | S. Suresh | M. Ball | L. Simpson | M. Wake | S. Olsen | M. Short | N. Dunn | A. Jackman | S. Hope | V. Anderson | R. Horne | J. Quach | G. Kennedy | M. Howard | J. Redman | N. Marshall | P. Liu | J. Douglas | K. Ward | S. Mukherjee | G. Love | A. Fedson | H. Wright | A. Walker | C. Nicholas | D. Paul | J. Bradley | G. Williams | B. Sweeney | S. Wong | D. Taylor | M. Thomas | J. Hung | A. Vakulin | R. Patterson | A. Foster | J. Yang | E. Hudson | S. Rowland | H. Williams | S. Dunn | J. Potter | M. Ng | M. Horswill | G. Parker | K. Kemp | D. Keenan | J. Veldhuis | M. Muhm | S. Jones | M. Weaver | I. Thomas | S. Garden | H. Gill
[1] I. Pavord,et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.
[2] Douglas G. Altman,et al. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey , 2016, PloS one.
[3] P. Williamson,et al. Core outcome sets and systematic reviews , 2016, Systematic Reviews.
[4] Masutaka Furue,et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. , 2014, The Journal of allergy and clinical immunology.
[5] D. Moher,et al. Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.
[6] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[7] D. Altman,et al. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol) , 2015, Trials.
[8] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[9] D. Moher,et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trialsqqq , 2018 .
[10] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[11] P. Williamson,et al. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people , 2012, Trials.
[12] S. Leeder,et al. The asthma health outcome indicators study , 1996, Australian and New Zealand journal of public health.
[13] Theresa Schilhab,et al. Issues to Consider , 2017 .
[14] H. Williams,et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. , 2015, The Journal of investigative dermatology.
[15] Jane M Blazeby,et al. Developing core outcome sets for clinical trials: issues to consider , 2012, Trials.
[16] Paula R. Williamson,et al. Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review , 2014, PloS one.
[17] P. Williamson,et al. Three nested RCTs of dual or single stakeholder feedback within Delphi surveys during core outcome and information set development , 2015, Trials.
[18] W. Busse,et al. Asthma outcomes workshop: overview. , 2012, The Journal of allergy and clinical immunology.
[19] N. Black. CONSORT , 1996, The Lancet.
[20] P. Williamson,et al. Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies , 2011, PLoS medicine.